Supreme Court Asked To Take Up Lupron Labeling Suit

Law360, Chicago (November 1, 2013, 5:50 PM EDT) -- A Nevada woman on Thursday petitioned the U.S. Supreme Court for a new trial in her suit accusing TAP Pharmaceutical Products Inc. and Abbott Laboratories of failing to warn her about the risks of their drug Lupron, claiming a federal judge was biased against her and excluded important evidence.

Karin Klein claims the Ninth Circuit erred when it upheld a lower court's decision to keep from a jury old labels for Lupron showing the companies had previously warned of bone density loss and thyroid problems in connection with the drug — warnings that were absent when Klein received the drug in...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!